Quality of Life (QOL)
0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Novo NordiskBAGSVAERD DENMARK, Denmark
1 programMulti-level, Multi-component Intervention PackageN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
Novo NordiskMulti-level, Multi-component Intervention Package
City TherapeuticsBody-Mind-Spirit
Clinical Trials (2)
Total enrollment: 2,200 patients across 2 trials
Cities for Better Health Childhood Obesity Prevention Initiative in JAPAN
Start: Jul 2025Est. completion: Sep 20272,200 patients
N/ARecruiting
Body-Mind-Spirit Action Group on the Well-being
Start: Apr 2023Est. completion: Jul 2024
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 2,200 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.